Aisling Capital Management as of June 30, 2019
Portfolio Holdings for Aisling Capital Management
Aisling Capital Management holds 14 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bridgebio Pharma (BBIO) | 44.4 | $103M | 3.8M | 26.97 | |
| Eidos Therapeutics | 15.0 | $35M | 1.1M | 31.08 | |
| Marker Therapeutics Ord | 6.8 | $16M | 2.0M | 7.92 | |
| Obseva Sa | 6.7 | $16M | 1.4M | 11.31 | |
| Avrobio Ord (AVRO) | 5.7 | $13M | 812k | 16.26 | |
| Biohaven Pharmaceutical Holding | 5.2 | $12M | 275k | 43.79 | |
| Aeglea Biotherapeutics | 3.8 | $8.8M | 1.3M | 6.85 | |
| Atreca Inc Cl A (BCEL) | 3.1 | $7.3M | 388k | 18.84 | |
| Sunesis Pharmaceuticals Inc Ne | 2.4 | $5.5M | 7.6M | 0.73 | |
| Zosano Pharma Corp | 2.3 | $5.3M | 16M | 0.33 | |
| Nabriva Therapeutics | 1.9 | $4.4M | 1.8M | 2.43 | |
| Arcus Biosciences Incorporated (RCUS) | 1.1 | $2.6M | 333k | 7.95 | |
| Verona Pharma Plc ads (VRNA) | 1.0 | $2.3M | 444k | 5.10 | |
| Aclaris Therapeutics (ACRS) | 0.6 | $1.4M | 635k | 2.19 |
